CyMedica Orthopedics today said it completed early enrollment of 159 patients in an FDA-regulated clinical trial of its E-Vive pain relief technology. The technology is designed for patients with knee osteoarthritis and is being studied in a randomized, prospective, double-blind, multisite, pivotal trial in adults. The trial will evaluate the company’s patented CyMotion neuromuscular strengthening […]
CyMedica Orthopedics
CyMedica raises $4m
CyMedica Orthopedics has raised approximately $4 million in a new round of equity financing, according to a recently posted SEC filing. Money in the round came from three anonymous sources, with the first date of sale noted as having occurred on May 31, according to the filing. CyMedica has not yet stated how it plans to […]
CyMedica launches another trial of muscle-strengthening device
CyMedica Orthopedics said it has launched a clinical trial to evaluate the effectiveness of its E-vive muscle-strengthening device and patient engagement system in knee osteoarthritis patients. Researchers will combine the data generated by the E-vive neuromuscular electrical stimulation device with the activity and health data collected by commercially available wearable smartwatch devices to determine the effect […]
CyMedica raises $3m
CyMedica Orthopedics has raised $3 million in a new round of debt and options financing, according to a recently posted SEC filing. Money in the round comes from 2 unnamed investors, with the first sale noted on September 26, according to the filing. The Scottsdale, Ariz.-based company is looking for an additional $2 million before closing […]
CyMedica launches trial of E-Vive knee surgery rehab device
CyMedica Orthopedics said today it enrolled the 1st patient in a clinical trial of its E-Vive neuro-muscular device, looking to explore its effectiveness in post-operative primary total knee arthroplasty rehabilitation. The Scottsdale, Ariz.-based company’s E-Vive wireless muscle stimulation device is designed to reduce post-surgical muscle atrophy, specifically losses in quadricep strength after knee surgery. “As […]
CyMedica wins CE Mark for QB1
CyMedica said yesterday it won CE Mark approval in the European Union for its QB1 muscle activation system. The QB1 combines a postoperative knee brace, form-fitting conductive garment and a neuromuscular electronic stimulation control interface, and is the 1st to use a close-loop power system that delivers high-intensity electrical muscle stimulation, the Scottsdale, Ariz.-based company […]
CyMedica pulls in $11.5m in Series A for orthopedic muscle atrophy device
Orthopedic muscle atrophy treatment device developer Cymedica Orthopedics said last Tuesday that it raised $11.5 million in a Series A financing round. The round was led by Research Corporation Technologies and California Technology Ventures, and included participation from Aphelion Capital and the founding group of investors. Another technology they are exploring are compression machines for […]